BRISTOL MYERS SQUIBB CO (BMY)
Health Care / Pharmaceuticals
$59.32
Above average across most dimensions. A solid candidate.
Buy
Score based on 4 of 5 models — moderate confidence
Key Metrics
Estimated Fair Value
Fair value above market price. ROE of 38% signals strong profitability. P/E of 17x is moderate for this quality level.
Model-based estimate, not a price target.
5-Model Analysis
Each model evaluates this stock from a different angle. Combined, they form the composite score above.
Piotroski
Strong
8/9
Buffett
Attractive
Business quality & competitive moat
Graham
Caution
Significantly above fair value
Lynch
Neutral
Growth rate vs price (PEG)
Greenblatt
Attractive
Top 25% (rank 22%)
Similar Stocks
Scores are algorithm-generated research tools, not investment recommendations. Past performance does not guarantee future results. Always do your own due diligence. Full disclaimer